Ping An Biomedical Plans to Acquire Three Tumor Cell-Related Patents
Ping An Biomedical announced a letter of intent for the planned acquisition of three tumor cell-related medical technology patents.
Story updates
07:35:25 PM UTC
SquawkNews
Ping An Biomedical entered a non-binding LOI to acquire three tumor cell-related medical technology patents for $2M—$2.5M. The deal is subject to due diligence and definitive agreements and is not expected to generate near-term material revenue.Material DetailsContext by AI AnalystThis is an early…
HONG KONG, Oct. 22, 2026 — Ping An Biomedical Co., Ltd. (NASDAQ:PASW) said it had entered into a letter of intent with Future Biotechnology Group Co., Limited regarding a planned acquisition of three tumor cell…